[1]
Kumar, S., Singh, A., Singh, N., Faizi, A., Mishra, B., Gupta, A. and Yadav, A. 2024. A Real World Analysis of Safety and Efficacy of Nilotinib when Used as First Line and Beyond: Retrospective Single Centre Study Representing Largest Cohort of Indian Patients Treated with Nilotinib. Asian Pacific Journal of Cancer Biology. 9, 2 (May 2024), 137-147. DOI:https://doi.org/10.31557/apjcb.2024.9.2.137-147.